At least one official pathway to legal ibogaine—either a law passed by Congress or an FDA (US drug regulator) rule—will require heart screening before anyone can use it. This is a lower bar than FDA guidance alone: it could be a bill text, a proposed FDA rule, or a condition letter from the FDA to a specific company.
The original prediction conflated two distinct processes—legislative design and regulatory rulemaking—into a single vague claim about a 'floor standard across all federal access pathways.' Sharpened to a falsifiable binary: does at least one federal vehicle (bill text, FDA draft guidance, or IND condition letter) formally mandate cardiac screening by the resolve date? August 2026 is ~15 months away. Congressional ibogaine bills are stalled; FDA guidance at that speed is unlikely. The political logic is sound but the timeline is aggressive. Confidence reduced significantly.